Title | Type | SJR | H index | Total Docs. (2003) | Total Docs. (3years) | Total Refs. (2003) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2003) | %Female (2003) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
157 | Cancer Immunity | journal | 0.327 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
156 | Cancer Journal | journal | 1.325 Q1 | 16 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
155 | Chinese Journal of Lung Cancer | journal | 0.100 Q4 | 21 | 101 | 101 | 1048 | 0 | 99 | 0.00 | 10.38 | 35.62 | |
154 | Electronic Journal of Oncology | journal | 0.111 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
153 | Environmental Carcinogenesis and Ecotoxicology Reviews | journal | 0.181 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
152 | European Journal of Cancer, Supplement | journal | 29 | 51 | 0 | 2131 | 0 | 0 | 0.00 | 41.78 | 25.33 | ||
151 | Gann Monographs on Cancer Research | book series | 0.101 Q4 | 10 | 29 | 17 | 1476 | 0 | 16 | 0.00 | 50.90 | 19.61 | |
150 | International Journal of Pediatric Hematology/Oncology | journal | 0.101 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
149 | Journal of Carcinogenesis | journal | 0.121 Q4 | 43 | 9 | 1 | 372 | 0 | 1 | 0.00 | 41.33 | 39.29 | |
148 | Journal of Tumor Marker Oncology | journal | 0.100 Q4 | 9 | 0 | 37 | 0 | 0 | 37 | 0.00 | 0.00 | 0.00 | |
147 | Leukaemia Risks in Relation to Benzene Exposure | conference and proceedings | 0.102 | 1 | 0 | 9 | 0 | 0 | 9 | 0.00 | 0.00 | 0.00 | |
146 | Oncology Forum | journal | 0.103 Q4 | 1 | 31 | 7 | 219 | 0 | 6 | 0.00 | 7.06 | 28.57 | |
145 | Progress in Experimental Tumor Research | book series | 20 | 14 | 0 | 1453 | 0 | 0 | 0.00 | 103.79 | 24.00 | ||
144 | Annals of Cancer Research and Therapy | journal | 0.104 Q4 | 7 | 20 | 23 | 554 | 1 | 22 | 0.11 | 27.70 | 9.68 | |
143 | Cancer Molecular Biology | journal | 0.101 Q4 | 4 | 3 | 40 | 87 | 1 | 40 | 0.00 | 29.00 | 55.56 | |
142 | National Toxicology Program technical report series | journal | 0.101 | 22 | 3 | 13 | 0 | 1 | 13 | 0.00 | 0.00 | 0.00 | |
141 | Women's Oncology Review | journal | 0.108 | 4 | 12 | 17 | 349 | 1 | 13 | 0.06 | 29.08 | 60.00 | |
140 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 4 | 17 | 598 | 3 | 17 | 0.00 | 149.50 | 14.75 | ||
139 | UroOncology | journal | 0.118 Q4 | 5 | 25 | 51 | 558 | 3 | 45 | 0.06 | 22.32 | 25.00 | |
138 | Cancer Forum | journal | 0.112 Q4 | 15 | 33 | 94 | 405 | 4 | 92 | 0.05 | 12.27 | 40.00 | |
137 | Onkologia Polska | journal | 0.117 Q4 | 7 | 30 | 48 | 671 | 4 | 48 | 0.08 | 22.37 | 45.12 | |
136 | Tumor Research | journal | 0.130 Q4 | 3 | 3 | 19 | 51 | 4 | 19 | 0.00 | 17.00 | 38.89 | |
135 | Nowotwory | journal | 0.107 Q4 | 11 | 57 | 63 | 1586 | 5 | 63 | 0.13 | 27.82 | 34.92 | |
134 | Pathogenesis | journal | 0.215 Q4 | 8 | 0 | 7 | 0 | 5 | 7 | 0.00 | 0.00 | 0.00 | |
133 | Turkish Journal of Cancer | journal | 0.110 Q4 | 10 | 26 | 72 | 524 | 5 | 72 | 0.06 | 20.15 | 39.45 | |
132 | Reports of Practical Oncology and Radiotherapy | journal | 0.121 Q4 | 36 | 15 | 40 | 444 | 8 | 37 | 0.17 | 29.60 | 31.58 | |
131 | Cancer Research, Therapy and Control | journal | 0.152 Q4 | 13 | 0 | 47 | 0 | 9 | 47 | 0.25 | 0.00 | 0.00 | |
130 | Breast Disease | journal | 0.165 Q4 | 36 | 19 | 84 | 1702 | 13 | 80 | 0.06 | 89.58 | 50.00 | |
129 | Biotherapy | journal | 0.107 Q4 | 8 | 75 | 296 | 1595 | 14 | 287 | 0.06 | 21.27 | 5.88 | |
128 | Chinese Journal of Cancer Research (discontinued) | journal | 0.108 Q4 | 41 | 66 | 214 | 1077 | 14 | 214 | 0.06 | 16.32 | 32.65 | |
127 | Journal of B.U.ON. | journal | 0.112 Q4 | 37 | 74 | 238 | 1508 | 15 | 215 | 0.06 | 20.38 | 42.77 | |
126 | Prostate Journal | journal | 0.266 Q4 | 7 | 0 | 48 | 0 | 17 | 43 | 0.35 | 0.00 | 0.00 | |
125 | Familial Cancer | journal | 0.339 Q3 | 67 | 19 | 32 | 726 | 19 | 29 | 0.59 | 38.21 | 45.88 | |
124 | Cancer Cell International | journal | 0.340 Q3 | 80 | 17 | 19 | 689 | 20 | 18 | 1.05 | 40.53 | 36.00 | |
123 | Journal of Environmental Science and Health, Part C: Toxicology and Carcinogenesis | journal | 59 | 6 | 30 | 831 | 20 | 29 | 0.58 | 138.50 | 25.00 | ||
122 | Clinical and Translational Oncology | journal | 0.108 Q4 | 61 | 97 | 218 | 2695 | 21 | 177 | 0.09 | 27.78 | 35.89 | |
121 | Journal of Cancer Epidemiology and Prevention | journal | 0.482 Q3 | 10 | 0 | 22 | 0 | 25 | 22 | 1.14 | 0.00 | 0.00 | |
120 | Molecular Cancer | journal | 0.618 Q3 | 196 | 42 | 9 | 2489 | 26 | 8 | 2.89 | 59.26 | 25.76 | |
119 | Voprosy Onkologii | journal | 0.110 Q4 | 13 | 118 | 368 | 1897 | 26 | 368 | 0.05 | 16.08 | 48.73 | |
118 | Journal of Brachytherapy International | journal | 0.305 Q3 | 12 | 0 | 62 | 0 | 31 | 61 | 0.52 | 0.00 | 0.00 | |
117 | Cancer Communications | journal | 79 | 274 | 279 | 451 | 33 | 279 | 0.12 | 1.65 | 35.87 | ||
116 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.174 Q4 | 50 | 0 | 70 | 0 | 33 | 70 | 0.62 | 0.00 | 0.00 | |
115 | Cancer Immunology Research | journal | 134 | 22 | 29 | 515 | 39 | 26 | 1.34 | 23.41 | 34.33 | ||
114 | Journal of Experimental Therapeutics and Oncology | journal | 0.345 Q3 | 40 | 31 | 38 | 1473 | 39 | 37 | 1.03 | 47.52 | 27.27 | |
113 | Current Problems in Cancer | journal | 0.343 Q3 | 47 | 25 | 49 | 761 | 43 | 46 | 1.33 | 30.44 | 22.22 | |
112 | Critical Reviews in Oncogenesis | journal | 1.503 Q1 | 57 | 0 | 11 | 0 | 44 | 11 | 0.00 | 0.00 | 0.00 | |
111 | Experimental Oncology | journal | 0.133 Q4 | 48 | 71 | 175 | 1666 | 46 | 173 | 0.26 | 23.46 | 39.34 | |
110 | Clinical Lung Cancer | journal | 0.224 Q4 | 74 | 66 | 161 | 2445 | 51 | 125 | 0.34 | 37.05 | 33.13 | |
109 | Technology in Cancer Research and Treatment | journal | 0.206 Q4 | 72 | 66 | 62 | 3135 | 62 | 61 | 1.00 | 47.50 | 22.08 | |
108 | Brain Tumor Pathology | journal | 0.371 Q3 | 45 | 16 | 67 | 358 | 65 | 67 | 0.84 | 22.38 | 13.79 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®